1. Home
  2. ABEO vs ORN Comparison

ABEO vs ORN Comparison

Compare ABEO & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • ORN
  • Stock Information
  • Founded
  • ABEO 1974
  • ORN 1994
  • Country
  • ABEO United States
  • ORN United States
  • Employees
  • ABEO N/A
  • ORN N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • ABEO Health Care
  • ORN Industrials
  • Exchange
  • ABEO Nasdaq
  • ORN Nasdaq
  • Market Cap
  • ABEO 256.9M
  • ORN 350.4M
  • IPO Year
  • ABEO 1980
  • ORN 2007
  • Fundamental
  • Price
  • ABEO $5.95
  • ORN $8.38
  • Analyst Decision
  • ABEO Strong Buy
  • ORN Strong Buy
  • Analyst Count
  • ABEO 6
  • ORN 2
  • Target Price
  • ABEO $18.00
  • ORN $11.25
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • ORN 349.2K
  • Earning Date
  • ABEO 08-11-2025
  • ORN 07-29-2025
  • Dividend Yield
  • ABEO N/A
  • ORN N/A
  • EPS Growth
  • ABEO N/A
  • ORN N/A
  • EPS
  • ABEO N/A
  • ORN 0.08
  • Revenue
  • ABEO N/A
  • ORN $824,375,000.00
  • Revenue This Year
  • ABEO N/A
  • ORN $4.34
  • Revenue Next Year
  • ABEO $322.37
  • ORN $11.09
  • P/E Ratio
  • ABEO N/A
  • ORN $106.05
  • Revenue Growth
  • ABEO N/A
  • ORN 15.58
  • 52 Week Low
  • ABEO $3.93
  • ORN $4.64
  • 52 Week High
  • ABEO $7.32
  • ORN $12.12
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 51.37
  • ORN 42.92
  • Support Level
  • ABEO $5.66
  • ORN $8.62
  • Resistance Level
  • ABEO $5.99
  • ORN $9.61
  • Average True Range (ATR)
  • ABEO 0.24
  • ORN 0.35
  • MACD
  • ABEO 0.01
  • ORN -0.12
  • Stochastic Oscillator
  • ABEO 74.19
  • ORN 0.81

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: